Monday, December 22, 2025 | 05:13 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Bharat Biotech starts human trials of Covid-19 vaccine in PGI Rohtak

Bharat Biotech got the country's drug regulator's approval to start clinical trials of its anti-Corona vaccine Covaxin recently

Covaxin, bharat biotech, covid, coronavirus, vaccine, drugs, medicine, pharma
premium

Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, Haryana Health Minister Vij said

Press Trust of India
The human trial of Bharat Biotech's anti-Covid-19 vaccine Covaxin began at Rohtak's Post-Graduate Institute of Medical Sciences on Friday, Haryana Health Minister Anil Vij tweeted.

Human trial with Corona vaccine (COVAXIN) of Bharat Biotech started at PGI Rohtak today, Vij, who is also the Home and Science & Technology minister said.

Three subjects were enrolled today. All have tolerated the vaccine very well. There were no adverse effects, Vij further said in his tweet.


Bharat Biotech got the country's drug regulator's approval to start clinical